Ieder jaar publiceert DICA de resultaten van de registraties. Daardoor ontstaat een beeld van de kwaliteit van de zorg in Nederland. De resultaten over 2019 zijn, per registratie, te vinden in de online jaarrapportage.


Publicaties met data uit de DMTR:

2020

Franken, M. G., Leeneman, B., Jochems, A., Schouwenburg, M. G., Aarts, M. J., van Akkooi, A. C., ... & Hospers, G. A. (2018). Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands. Cancers (Basel). 2020;12(4):1003. Published 2020 Apr 18. doi:10.3390/cancers12041003

Monique K van der Kooij, Marjolein J A L Wetzels, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, … & Ellen Kapiteijn (2020). Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response. Cancers (Basel). 2020;12(8):E2072. Published 2020 Jul 27. doi:10.3390/cancers12082072

Rik J. Verheijden , Anne May , Christian Blank , Maureen J.B. Aarts , Franchette W.P.J. van den Berkmortel , Alfonsus J.M. van den Eertwegh , … & Karijn P.M. Suijkerbuijk (2020). Clin Cancer Res. 2020;26(9):2268-2274. doi:10.1158/1078-0432.CCR-19-3322

Stephanie A Blankenstein, Maureen J B Aarts, Franchette W P J van den Berkmortel, Marye J Boers-Sonderen, Alfons J M van den Eertwegh, Margreet G Franken, … & Alexander C J van Akkooi. Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy. Cancers (Basel) 2020 May 7;12(5):1176. doi: 10.3390/cancers12051176.

van Zeijl MCT, Ismail RK, de Wreede LC, et al. Real-world outcomes of advanced melanoma patients not represented in phase III trials. Int. J. Cancer. 2020;1–10. https://doi.org/10.1002/ijc.33162

van Zeijl MCT, Boer FL, van Poelgeest MIE, et al. Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based study [published online ahead of print, 2020 Aug 4]. Eur J Cancer. 2020;137:127-135. doi:10.1016/j.ejca.2020.05.021

2019

Jochems A, van der Kooij MK, Fiocco M, Schouwenburg MG, Aarts MJ, van Akkooi AC, … & Kapiteijn E. (2019). Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry. Cancers (Basel). 2019 Jul 18;11(7):1007. doi:10.3390/cancers11071007.

Leeneman, B., Franken, M. G., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., van den Eertwegh, A. J. M., … & Uyl-de Groot (2019). A nationwide cost of illness study of metastatic cutaneous melanoma in the Netherlands. Value in Health. Nov-2019, 22, p. S534-S534 1 p.

Schouwenburg MG, Suijkerbuijk KPM, Koornstra RHT, Jochems A, van Zeijl MCT, van den Eertwegh AJM, Haanen JBAG, Aarts MJ, Akkooi ACJV, Berkmortel FWPJVD, Groot JWB, Hospers GAP, Kapiteijn E, Kruit WH, Piersma D, van Rijn RS, Ten Tije AJ, Vreugdenhil G, Hoeven JJMV, Wouters MWJM. Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH? Cancers (Basel). 2019 Dec 4;11(12).

2018

Jochems, A., Leeneman, B., Franken, M. G., Schouwenburg, M. G., Aarts, M. J., van Akkooi, A. C., ... & Haanen, J. B. (2018). Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands. Anti-cancer drugs, 29(6), 572-578. https://journals.lww.com/anti-cancerdrugs/Abstract/2018/07000/Real_world_use,_safety,_and_survival_of_ipilimumab.11.aspx

van Zeijl, M.C.T., van den Eertwegh, A.J.M., Wouters, M.W.J.M. Jochems, A., Schouwenburg, M.G., Haanen, J.B.A.G., ... & van der Hoeven, K.J.M. (2018). Recente behandelresultaten van uitgezaaid melanoom: Gegevens uit de Dutch Melanoma Treatment Registry. Nederlands Tijdschrift voor Geneeskunde, 2018;162:D242 https://www.ntvg.nl/artikelen/recente-behandelresultaten-van-uitgezaaid-melanoom

2017

Jochems, A., Schouwenburg, M. G., Leeneman, B., Franken, M. G., van den Eertwegh, A. J., Haanen, J. B., ... & Blokx, W. A. (2017). Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands. European Journal of Cancer, 72, 156-165. https://www.ncbi.nlm.nih.gov/pubmed/28030784

2015

Franken, M., Leeneman, B., Schouwenburg, M., Jochems, A., Wouters, M., Van den Eertwegh, F., ... & Uyl-de Groot, C. (2015). The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making. Value in Health, 18(7), A491. https://www.ncbi.nlm.nih.gov/pubmed/26532754

Leeneman, B., Franken, M. G., Jochems, A., Schouwenburg, M. G., Wouters, M. W., Van den Eertwegh, A. J., ... & Uyl-de Groot, C. A. (2015). Improved survival with ipilimumab in patients with advanced melanoma in real-world clinical practice: first results of the dutch melanoma treatment registry. Value in Health, 18(7), A440. https://www.ncbi.nlm.nih.gov/pubmed/26532474

2014

Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, Rob R H van den Brom, Geke A P Hospers, Alfonsus J M van den Eertwegh, … & Christian U Blank (2014). Lactate Dehydrogenase as a Selection Criterion for Ipilimumab Treatment in Metastatic Melanoma. Cancer Immunol Immunother. 2014 May;63(5):449-58. doi: 10.1007/s00262-014-1528-9. Epub 2014 Mar 8.